HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Stefano Conte Ramadan Jashari Willem Daenen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conte, S. Articles by Daenen, W. Search for Related Content PubMed PubMed Citation Articles by Conte, S. Articles by Daenen, W.

Eur J Cardiothorac Surg 1999;15:143-149
© 1999 Elsevier Science NL

Homograft valve insertion for pulmonary regurgitation late after valveless repair of right ventricular outflow tract obstruction¹

^a Department of Cardiac Surgery, Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
^b Pediatric Cardiology, `Gasthuisberg' University Hospital, Leuven, Belgium

Received 14 September 1998; received in revised form 23 November 1998; accepted 1 December 1998.

^* Correspondence author. Tel. +32-1634-4260; fax: +32-1634-4616.

Objective: Pulmonary regurgitation after valveless repair of right ventricular outflow tract obstruction (RVOTO) results in progressive right ventricular (RV) dilatation and dysfunction in an increasing number of patients. Since 1989, we have exclusively used cryopreserved homografts to restore pulmonary valve competence in these patients. Our 9-year-experience with pulmonary valve insertion (PVI) in such cases has been reviewed to evaluate the indications for this procedure and its benefits. Methods: From 1989 to 1998, 49 patients (original diagnosis: tetralogy of Fallot in 42 patients and pulmonary stenosis in seven) aged from 3 to 42 years (mean 18±9 years) underwent PVI with homografts late (mean 13±7 years) after valveless repair of RVOTO (transannular patch, n=38; pulmonary valvulotomy±infundibular patch, n=11). Preoperatively, all patients had severe pulmonary regurgitation, cardiomegaly, significant to severe RV dilatation and dysfunction, fatigue, reduced exercise tolerance, and were in NYHA class II (n=43) or III (n=6). Ten patients had ventricular arrhythmia. Results: There was one early death, due to air embolism, and one late death, due to ventricular arrhythmia. All survivors but one, who subsequently underwent heart transplant, had symptomatic improvement after homograft insertion. The mean RV end-diastolic diameter decreased from 38±9 to 26±8 mm (P<0.01), and cardiothoracic ratio decreased from 0.62±0.07 to 0.54±0.04 (P<0.01). Good late homograft function was the rule, with all the survivors being free of reoperation for valve failure. At a mean follow-up of 42±28 months, 41 patients (87% of the survivors) were in New York Heart Association (NYHA) class I and six in class II. Within this group three patients are still in treatment for RV failure and five for ventricular arrhythmias. In these patients, the average interval between RVOTO repair and PVI was significantly longer than in the others (18±7 vs. 12±6 years, P<0.01). Conclusion: Homograft PVI is safe and provides clinical improvement with a significant reduction in RV volume overload and excellent mid-term results in most patients with severe PR late after RVOTO repair. This procedure should be undertaken early in symptomatic patients, before severe RV failure and ventricular arrhythmias ensue.

Key Words: Reoperation • Congenital heart disease • Tetralogy of Fallot • Pulmonary valve • Homografts

This article has been cited by other articles:

				E. Troost, B. Meyns, W. Daenen, F. Van de Werf, M. Gewillig, K. Van Deyk, P. Moons, and W. Budts Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration Eur. Heart J., October 2, 2007; 28(20): 2503 - 2509. [Abstract] [Full Text] [PDF]

				J. Odim, H. Laks, and T. Tung Risk factors for early death and reoperation following biventricular repair of pulmonary atresia with intact ventricular septum. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 659 - 665. [Abstract] [Full Text] [PDF]

				P A Davlouros, K Niwa, G Webb, and M A Gatzoulis The right ventricle in congenital heart disease Heart, April 1, 2006; 92(suppl_1): i27 - i38. [Abstract] [Full Text] [PDF]

				S. Khambadkone, L. Coats, A. Taylor, Y. Boudjemline, G. Derrick, V. Tsang, J. Cooper, V. Muthurangu, S. R. Hegde, R. S. Razavi, et al. Percutaneous Pulmonary Valve Implantation in Humans: Results in 59 Consecutive Patients Circulation, August 23, 2005; 112(8): 1189 - 1197. [Abstract] [Full Text] [PDF]

				J. A. Quintessenza, J. P. Jacobs, V. O. Morell, J. M. Giroud, and R. J. Boucek Initial Experience With a Bicuspid Polytetrafluoroethylene Pulmonary Valve in 41 Children and Adults: A New Option For Right Ventricular Outflow Tract Reconstruction Ann. Thorac. Surg., March 1, 2005; 79(3): 924 - 931. [Abstract] [Full Text] [PDF]

				C. Lim, J. Y. Lee, W.-H. Kim, S.-C. Kim, J.-Y. Song, S.-J. Kim, J.-H. Choh, and C. Whan Kim Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 728 - 734. [Abstract] [Full Text] [PDF]

				K. G. Warner, P. K. H. O'Brien, J. Rhodes, A. Kaur, D. A. Robinson, and D. D. Payne Expanding the indications for pulmonary valve replacement after repair of tetralogy of fallot Ann. Thorac. Surg., October 1, 2003; 76(4): 1066 - 1071. [Abstract] [Full Text] [PDF]

				P. Bonhoeffer, Y. Boudjemline, S. A. Qureshi, J. Le Bidois, L. Iserin, P. Acar, J. Merckx, J. Kachaner, and D. Sidi Percutaneous insertion of the pulmonary valve J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1664 - 1669. [Abstract] [Full Text] [PDF]

				M.G. Hazekamp, M.M.J. Kurvers, P.H. Schoof, H.W. Vliegen, B.M. Mulder, A.A.W. Roest, J. Ottenkamp, and R.A.E. Dion Pulmonary valve insertion late after repair of Fallot's tetralogy Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 667 - 670. [Abstract] [Full Text] [PDF]

				R. Jashari, B. Van Hoeck, M. Gaudino, W. Daenen, T. Van Geldorp, P. Kalmar, and Y. Goffin Are pulmonary homografts which were subjected to pulmonary hypertension more appropriate for aortic valve replacement than normal pulmonary homografts? A long-term multicentric echography study Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 140 - 145. [Abstract] [Full Text] [PDF]